cla
Cla (Conjugated Linoleic Acid) is a dietary supplement.
Conjugated Linoleic Acid
Key facts
- Active ingredient
- Conjugated Linoleic Acid
- Type
- Supplement
What is Cla?
From the FDA label:A fatty acid marketed for body composition; evidence is mixed.
What the evidence says
What Cla is
Commonly used for
What the evidence shows
Typical dosage
Safety
Side effects
Interactions & cautions
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Summarized from public health authorities; general reference, not medical advice. Talk to a licensed healthcare professional before starting any supplement.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Conjugated Linoleic Acid
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 69 reports naming Conjugated Linoleic Acid — the active ingredient in Cla, and the FDA flagged 43% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dizziness6 reports
- fatigue5 reports
- nausea5 reports
- pruritus5 reports
- diarrhoea4 reports
- dyspnoea4 reports
- arthralgia3 reports
- headache3 reports
Read these as a signal, not a rate. A report does not mean Conjugated Linoleic Acid caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Cla head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.